Scarica l'app Stockscreener
85.94
1.88%
-1.65
Dopo l'orario di chiusura:
87.65
1.71
+1.99%
Billiontoone Inc Borsa (BLLN) Ultime notizie
January 2026's Top Growth Companies With Insider Confidence - Yahoo Finance
BillionToOne, Inc. Announces Selection of Northstar Select as New Liquid Biopsy Test for LC-SCRUM-TRY Clinical Study at National Cancer Center Hospital East - MarketScreener
BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East - PR Newswire
3 Stocks Estimated To Be Up To 48.4% Below Intrinsic Value - Yahoo Finance
BillionToOne (BLLN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
BillionToOne Earnings Notes - Trefis
Med-tech IPOs shoot for the stars in 2025 - BioWorld MedTech
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference - 富途牛牛
BillionToOne stock in focus before Monday open after Friday jump, JPMorgan conference next - ts2.tech
BillionToOne (BLLN) Stock Update: Friday Rally, Analyst Price Targets, and the Next Catalysts Before Nasdaq Reopens - ts2.tech
BillionToOne Stock (NASDAQ: BLLN) News: Weekend Market Wrap, Analyst Targets, and What to Watch Before Monday’s Open - TechStock²
BillionToOne Stock (NASDAQ: BLLN) Rises Into the Weekend as Analyst Targets Point Higher — What Investors Need to Know Before Monday - ts2.tech
Should I buy BillionToOne, Inc. (BLLN) - Zacks Investment Research
Evommune and BillionToOne climb on trading debut - MSN
BillionToOne (BLLN) Is Down 6.7% After Joining the S&P Total Market IndexWhat's Changed - simplywall.st
BillionToOne falls -5.5% - MSN
BillionToOne: An Interesting Set-Up Into 2026 - Seeking Alpha
BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025 - ts2.tech
BillionToOne Adds Genmab CFO Anthony Pagano to Board, Names Him Audit Chair - TipRanks
Analysts Are Bullish on These Healthcare Stocks: Gilead Sciences (GILD), BillionToOne, Inc. Class A (BLLN) - The Globe and Mail
BillionToOne’s Earnings Call: Strong Growth and Strategic Outlook - TipRanks
BillionToOne, Inc. (NASDAQ:BLLN) Q3 2025 earnings call transcript - MSN
symbol__ Stock Quote Price and Forecast - CNN
Transcript : BillionToOne, Inc., Q3 2025 Earnings Call, Dec 09, 2025 - marketscreener.com
November reignites med-tech momentum with $4.7B raised - BioWorld MedTech
These Bay Area companies are IPO contenders in 2026 - The Business Journals
BillionToOne, Inc.: Strong Financial Performance and Strategic Market Positioning Drive Buy Rating - TipRanks
BillionToOne (BLLN) Revenue Surge Tests Bullish Growth Narrative Despite Ongoing EPS Losses - Sahm
BillionToOne, Inc.: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks
BillionToOne, Inc. SEC 10-Q Report - TradingView — Track All Markets
BillionToOne price target lowered to $145 from $150 at JPMorgan - MSN
BillionToOne stock rating reiterated at Overweight by Piper Sandler - Investing.com South Africa
Jim Cramer Says BillionToOne Has a “Fantastic Story” Within the Diagnostics Space - MSN
BillionToOne Swings To Profit In Q3; Sees Q4 Revenue Soaring Up To 100% - Nasdaq
BillionToOne’s Strong Growth Potential and Strategic Integration Drive Buy Rating - TipRanks
BTIG Reiterates 'Buy' Rating for BillionToOne (BLLN) with PT of $160 | BLLN Stock News - GuruFocus
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% By Investing.com - Investing.com Nigeria
Billiontoone Q3 2025 Earnings Call Transcript - MarketBeat
BillionToOne Q3 2025 presentation slides: Revenue soars 117% as profitability achieved - Investing.com Canada
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% - Investing.com
Earnings call transcript: BillionToOne's strong Q3 2025 lifts stock 3.19% - Investing.com
BillionToOne appoints Genmab CFO Anthony Pagano to board - Investing.com
BillionToOne sees Q4 revenue $84M-$90M, consensus $80.14M - TipRanks
BillionToOne Appoints Anthony Pagano as Audit Chair - TipRanks
BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours - marketscreener.com
1.12%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):